XY0YX28Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8

Q: What is the ICD-10-PCS code for taurolidine Anti-infective and Heparin Anticoagulant?

The ICD-10-PCS Alphabetic Index lists Taurolidine Anti-infective and Heparin Anticoagulant under code XY0YX28, Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8, billable on inpatient claims in fiscal year 2027.

New Technology›Extracorporeal›Introduction

Billable / Specific Code

ICD-10-PCS XY0YX28

CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.

XY0YX28 is a billable ICD-10-PCS procedure code for Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Taurolidine Anti-infective and Heparin Anticoagulant. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.

Code Identity

ICD-10-PCS Code

XY0YX28

Billable Status

Yes — Valid for Submission

Code Describes

Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8

Short Description

Extracorporeal Introduce of Taurolidine/Heparin, New Tech 8

Parent Code

XY0 New Technology, Extracorporeal, Introduction

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

Position	Designation	Value	Meaning
1	Section	X	New Technology
2	Body System	Y	Extracorporeal
3	Operation	0	Introduction
4	BodyPart	Y	Extracorporeal
5	Approach	X	External
6	Device/Substance/Technology	2	Taurolidine Anti-infective and Heparin Anticoagulant
7	Qualifier	8	New Technology Group 8

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XY0YX28 as Taurolidine Anti-infective and Heparin Anticoagulant. These index entries lead to this code:

Taurolidine Anti-infective and Heparin Anticoagulant

Direct entry for this code

New Technology, Taurolidine Anti-infective and Heparin Anticoagulant

Direct entry for this code

DefenCath(tm)

Anatomy or device term that leads here

To code taurolidine anti-infective and heparin anticoagulant, open the FY 2027 ICD-10-PCS Alphabetic Index at Taurolidine Anti-infective and Heparin Anticoagulant. The entry lists XY0YX28 directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM021

Administration of therapeutic substances, NEC

Clinical domain: Administration of Therapeutic Substances

Similar Procedure Codes

Questions About XY0YX28

Is XY0YX28 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for taurolidine Anti-infective and Heparin Anticoagulant?

The ICD-10-PCS Alphabetic Index lists Taurolidine Anti-infective and Heparin Anticoagulant under code XY0YX28, Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8, billable on inpatient claims in fiscal year 2027.

What do the characters in XY0YX28 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character Y is the Body System (Extracorporeal); the 3rd character 0 is the Operation (Introduction); the 4th character Y is the BodyPart (Extracorporeal); the 5th character X is the Approach (External); the 6th character 2 is the Device/Substance/Technology (Taurolidine Anti-infective and Heparin Anticoagulant); the 7th character 8 is the Qualifier (New Technology Group 8).